323 related articles for article (PubMed ID: 3037889)
21. Enalapril versus captopril: a double-blind multicentre comparison in essential hypertension.
Rumboldt Z; Marinković M; Drinovec J
Int J Clin Pharmacol Res; 1988; 8(3):181-8. PubMed ID: 2841251
[TBL] [Abstract][Full Text] [Related]
22. Clinical experience with the angiotensin converting enzyme inhibitor captopril.
Walter NM; Whitworth JA; Kincaid-Smith P
Clin Exp Pharmacol Physiol Suppl; 1982; 7():117-21. PubMed ID: 6291829
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
24. [Comparison of the efficacy of captopril and enalapril in single doses in the treatment of arterial hypertension. Evaluation by means of non-invasive ambulatory monitoring].
Valori C; Gambini G; Canini F; Marinelli M; Rossi S; Pinchi G
Clin Ter; 1989 Jul; 130(1):37-44. PubMed ID: 2551565
[TBL] [Abstract][Full Text] [Related]
25. Comparison of captopril and enalapril in patients with severe chronic heart failure.
Packer M; Lee WH; Yushak M; Medina N
N Engl J Med; 1986 Oct; 315(14):847-53. PubMed ID: 3018566
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the efficacy and tolerability of the combination delapril plus indapamide in the treatment of mild to moderate essential hypertension: a randomised, multicentre, controlled study.
Rosei EA; Rizzoni D;
J Hum Hypertens; 2003 Feb; 17(2):139-46. PubMed ID: 12574793
[TBL] [Abstract][Full Text] [Related]
27. [Treatment of severe arterial hypertension with captopril (SQ 14.225) (author's transl)].
Di Giulio S; Perez-Ramirez JL; Jamoun P; Grünfeld JP; Meyer P
Nouv Presse Med; 1981 Apr; 10(19):1551-5. PubMed ID: 6269557
[TBL] [Abstract][Full Text] [Related]
28. Treatment of hypertension in the very old.
Otterstad JE; Ruilope LM
Int J Clin Pract Suppl; 2000 Nov; (114):10-9. PubMed ID: 11221289
[TBL] [Abstract][Full Text] [Related]
29. Studies of captopril alone and in combination with the benzothiazepine diltiazem or the dihydropyridine nifedipine in treating essential hypertension.
Singer DR; Markandu ND; Cappuccio FP; MacGregor GA
J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S51-4. PubMed ID: 1725544
[TBL] [Abstract][Full Text] [Related]
30. Quality of life and antihypertensive therapy in men. A comparison of captopril with enalapril. The Quality-of-Life Hypertension Study Group.
Testa MA; Anderson RB; Nackley JF; Hollenberg NK
N Engl J Med; 1993 Apr; 328(13):907-13. PubMed ID: 8446137
[TBL] [Abstract][Full Text] [Related]
31. [Ramipril effects on 24 hour profile of blood pressure in patients with mild and moderate hypertension].
Kukushkin SK; Lebedev AV; Manoshkina EM; Shamarin VM
Ter Arkh; 1998; 70(9):69-71. PubMed ID: 9821232
[TBL] [Abstract][Full Text] [Related]
32. [Effectiveness and tolerance of benazepril versus captopril in patients with hypertension].
Ol'binskaia LI; Golubev SA; Morozova TE
Klin Med (Mosk); 1995; 73(5):36-8. PubMed ID: 8815273
[TBL] [Abstract][Full Text] [Related]
33. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
McMahon FG; Weinstein SP; Rowe E; Ernst KR; Johnson F; Fujioka K;
J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224
[TBL] [Abstract][Full Text] [Related]
34. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
[TBL] [Abstract][Full Text] [Related]
35. Superior effect of an angiotensin-converting enzyme inhibitor over a diuretic for reducing aortic systolic pressure.
Jiang XJ; O'Rourke MF; Zhang YQ; He XY; Liu LS
J Hypertens; 2007 May; 25(5):1095-9. PubMed ID: 17414675
[TBL] [Abstract][Full Text] [Related]
36. Neutral endopeptidase versus angiotensin converting enzyme inhibition in essential hypertension.
Favrat B; Burnier M; Nussberger J; Lecomte JM; Brouard R; Waeber B; Brunner HR
J Hypertens; 1995 Jul; 13(7):797-804. PubMed ID: 7594444
[TBL] [Abstract][Full Text] [Related]
37. [Differential therapeutic topics in antihypertensive therapy. What can angiotensin-converting enzyme inhibitors accomplish?].
Noack E
Z Kardiol; 1988 Jul; 77(7):413-24. PubMed ID: 2850683
[TBL] [Abstract][Full Text] [Related]
38. ACE-inhibitors in the treatment of elderly hypertensives.
M'Buyamba-Kabangu JR; Fagard R; Lijnen P; Staessen J; Van Hoof R; Amery A
Geriatrics; 1987 Jun; 42(6):45-9. PubMed ID: 3034739
[TBL] [Abstract][Full Text] [Related]
39. [The treatment of severe arterial hypertension in patients with chronic kidney failure with captopril and beta-adrenoblockaders].
Ermolenko VM; Lifshits NL; Zisel'man SB; Tatsievskiĭ VA
Urol Nefrol (Mosk); 1991; (3):41-8. PubMed ID: 1871923
[TBL] [Abstract][Full Text] [Related]
40. Effects of converting-enzyme inhibitors on the renin-angiotensin-aldosterone, bradykinin, and arachidonic acid-prostaglandin systems: correlation of chemical structure and biologic activity.
Zusman RM
Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):13-23. PubMed ID: 3037886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
